European Journal of Clinical Pharmacology

, Volume 20, Issue 6, pp 413–416

Reduction of menopausal hot flushes by methyldopa

A double blind crossover trial
  • B. -I. Nesheim
  • T. Sætre
Originals

Summary

In a double-blind study, methyldopa was shown to be significantly more effective than placebo in reducing menopausal hot flushes. The median reduction in the number of hot flushes was 38% with placebo and 65% with methyldopa. The active metabolite of methyldopa, alpha-methylnoradrenaline, is an alpha2-adrenoceptor agonist. Since the alpha2-adrenoceptor agonist clonidine also reduces hot flushes, while the alpha2-adrenoceptor antagonist yohimbine produces flushes, it is speculated that menopausal hot flushes might result from a reduced stimulation of alpha2-adrenoceptors, probably in the CNS.

Key words

methyldopa menopause hot flushes alpha2-adrenoceptor agonist 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Hutton JD, Murray MAF, Jacobs HS, James VHT (1978) Relation between plasma oestrone and oestradiol and climacteric symptoms. Lancet 1: 678–681Google Scholar
  2. 2.
    Clayden JR, Bell JW, Pollard P (1974) Menopausal flushing: Double-blind trial of a non-hormonal medication. Br Med J 1: 409–412Google Scholar
  3. 3.
    Starke K, Endo T (1976) Presynaptic α-adrenoceptors. Gen Pharmacol 7: 307–312Google Scholar
  4. 4.
    Starke K, Borowski E, Endo T (1975) Preferential blockade of presynaptic α-adrenoceptors by yohimbine. Eur J Pharmacol 34: 385–388Google Scholar
  5. 5.
    Garfield SL, Gershon S, Sletten I, Sundland D, Ballon S (1967) Chemically induced anxiety. Int J Neuropsychiatry 3: 426–433Google Scholar
  6. 6.
    Coope J, Thomson JM, Poller L (1975) Effects of “natural oestrogen” replacement therapy on menopausal symptoms and blood clotting. Br Med J 4: 139–143Google Scholar
  7. 7.
    Baumgardner SB, Condrea H, Daane TA et al (1978) Replacement estrogen therapy for menopausal vasomotor flushes. Obstet Gynaecol 51: 445–452Google Scholar
  8. 8.
    Coope J, Williams S, Patterson JS (1978) A study of the effectiveness of propranolol in menopausal hot flushes. Br J Obstet Gynaecol 85: 472–475Google Scholar
  9. 9.
    Heritage AS, Stumpf WE, Sar M, Grant LD (1980) Brainstem catecholamine neurons are target sites for sex steroid hormones. Science 207: 1377–1379Google Scholar
  10. 10.
    Fishman J, Norton B (1975) Catechol estrogen formation in the central nervous system of the rat. Endocrinology 96: 1054–1059Google Scholar
  11. 11.
    Ball P, Knuppen R, Haupt M et al. (1972) Interactions between estrogens and catecholamines. J Clin Endocrinol 34: 736–746Google Scholar
  12. 12.
    Lloyd T, Weisz J, Breakfield XO (1978) The catechol estrogen, 2-hydroxyestradiol, inhibits catechol-O-methyltransferase activity in neuroblastoma cells. J Neurochem 31: 245–250Google Scholar

Copyright information

© Springer-Verlag 1981

Authors and Affiliations

  • B. -I. Nesheim
    • 1
  • T. Sætre
    • 1
  1. 1.Department of Gynaecology and Obstetrics, Akershus Central HospitalUniversity of OsloNorway

Personalised recommendations